{"name":"Medtronic BRC","slug":"medtronic-brc","ticker":"","exchange":"","domain":"","description":"Medtronic BRC is a specialized pharmaceutical company focused on developing and marketing innovative diuretic solutions. The company's portfolio includes three marketed products that address various fluid management needs in patients.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Diuretic Increase (DI)","genericName":"Diuretic Increase (DI)","slug":"diuretic-increase-di","indication":"Heart failure with fluid overload (presumed, based on diuretic enhancement indication)","status":"marketed"},{"name":"Diuretic Suspension (DS)","genericName":"Diuretic Suspension (DS)","slug":"diuretic-suspension-ds","indication":"Edema associated with congestive heart failure","status":"marketed"}]}],"pipeline":[{"name":"Diuretic Increase (DI)","genericName":"Diuretic Increase (DI)","slug":"diuretic-increase-di","phase":"marketed","mechanism":"Diuretic Increase (DI) is a device-based therapy from Medtronic that enhances diuretic efficacy, likely through optimized drug delivery or physiological modulation to increase urine output.","indications":["Heart failure with fluid overload (presumed, based on diuretic enhancement indication)"],"catalyst":""},{"name":"Diuretic Suspension (DS)","genericName":"Diuretic Suspension (DS)","slug":"diuretic-suspension-ds","phase":"marketed","mechanism":"Diuretic Suspension promotes fluid and electrolyte excretion through the kidneys to reduce fluid overload and blood pressure.","indications":["Edema associated with congestive heart failure","Hypertension","Fluid overload"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}